Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion

J Nutr Biochem. 2016 Jul:33:91-102. doi: 10.1016/j.jnutbio.2016.02.009. Epub 2016 Mar 21.

Abstract

Tracer studies suggest that phospholipid DHA (PL-DHA) more effectively targets the brain than triglyceride DHA (TAG-DHA), although the mechanism and whether this translates into higher brain DHA concentrations are not clear. Rats were gavaged with [U-(3)H]PL-DHA and [U-(3)H]TAG-DHA and blood sampled over 6h prior to collection of brain regions and other tissues. In another experiment, rats were supplemented for 4weeks with TAG-DHA (fish oil), PL-DHA (roe PL) or a mixture of both for comparison to a low-omega-3 diet. Brain regions and other tissues were collected, and blood was sampled weekly. DHA accretion rates were estimated using the balance method. [U-(3)H]PL-DHA rats had higher radioactivity in cerebellum, hippocampus and remainder of brain, with no differences in other tissues despite higher serum lipid radioactivity in [U-(3)H]TAG-DHA rats. TAG-DHA, PL-DHA or a mixture were equally effective at increasing brain DHA. There were no differences between DHA-supplemented groups in brain region, whole-body, or tissue DHA accretion rates except heart and serum TAG where the PL-DHA/TAG-DHA blend was higher than TAG-DHA. Apparent DHA β-oxidation was not different between DHA-supplemented groups. This indicates that more labeled DHA enters the brain when consumed as PL; however, this may not translate into higher brain DHA concentrations.

Keywords: Brain; Docosahexaenoic acid; Phospholipid; Serum; Triacylglycerol; Uptake.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism*
  • Brain Stem / metabolism
  • Deficiency Diseases / blood
  • Deficiency Diseases / diet therapy*
  • Deficiency Diseases / metabolism
  • Dietary Supplements*
  • Docosahexaenoic Acids / administration & dosage
  • Docosahexaenoic Acids / deficiency
  • Docosahexaenoic Acids / metabolism
  • Docosahexaenoic Acids / therapeutic use*
  • Fatty Acids, Essential / deficiency*
  • Fatty Acids, Omega-3 / blood
  • Fatty Acids, Omega-3 / metabolism
  • Fatty Acids, Omega-6 / blood
  • Fatty Acids, Omega-6 / metabolism
  • Male
  • Neurons / metabolism*
  • Organ Specificity
  • Phosphatidylcholines / blood
  • Phosphatidylcholines / metabolism
  • Phosphatidylcholines / therapeutic use
  • Phospholipids / blood
  • Phospholipids / metabolism
  • Phospholipids / therapeutic use*
  • Random Allocation
  • Rats, Long-Evans
  • Triglycerides / blood
  • Triglycerides / metabolism
  • Triglycerides / therapeutic use
  • Tritium

Substances

  • Fatty Acids, Essential
  • Fatty Acids, Omega-3
  • Fatty Acids, Omega-6
  • Phosphatidylcholines
  • Phospholipids
  • Triglycerides
  • Tritium
  • Docosahexaenoic Acids

Grants and funding